Portage Biotech
PRTG
#10218
Rank
₹1.17 B
Marketcap
Country
₹516.43
Share price
0.91%
Change (1 day)
56.50%
Change (1 year)
Categories
Revenue for Portage Biotech (PRTG)
Revenue in 2024 (TTM): N/A
In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Portage Biotech from 2008 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2024 (TTM)  | N/A | |
| 2023 | N/A | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | -100% |
| 2012 | ₹5.38 M | |
| 2011 | N/A | -100% |
| 2010 | ₹28.49 M | -93012.11% |
| 2009 | -₹0.04 Million | -100.84% |
| 2008 | ₹3.65 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | ₹12.24 B | N/A | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |